NO20055563L - Midler for behandlingen av lavere abdominale lidelser - Google Patents
Midler for behandlingen av lavere abdominale lidelserInfo
- Publication number
- NO20055563L NO20055563L NO20055563A NO20055563A NO20055563L NO 20055563 L NO20055563 L NO 20055563L NO 20055563 A NO20055563 A NO 20055563A NO 20055563 A NO20055563 A NO 20055563A NO 20055563 L NO20055563 L NO 20055563L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- lower abdominal
- abdominal disorders
- disorders
- pantoprazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Abstract
Oppfirmelsen vedrører anvendelsen av pantoprazol i behandlingen av lavere abdominale lidelser.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010168 | 2003-05-06 | ||
EP03016362 | 2003-07-19 | ||
PCT/EP2004/050694 WO2004098599A2 (en) | 2003-05-06 | 2004-05-04 | Proton pump inhibitors for the treatment of lower abdominal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055563L true NO20055563L (no) | 2005-11-24 |
Family
ID=33436110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055563A NO20055563L (no) | 2003-05-06 | 2005-11-24 | Midler for behandlingen av lavere abdominale lidelser |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060235053A1 (no) |
EP (1) | EP1660084A2 (no) |
AU (1) | AU2004237362A1 (no) |
CA (1) | CA2524268A1 (no) |
MX (1) | MXPA05011699A (no) |
NO (1) | NO20055563L (no) |
WO (1) | WO2004098599A2 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
US8512761B2 (en) | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
PL1976532T3 (pl) | 2006-01-27 | 2016-05-31 | Univ Yale | Szybko działający inhibitor wydzielania kwasu żołądkowego |
RU2008152196A (ru) * | 2006-06-15 | 2010-07-20 | Новартис АГ (CH) | Композиции, включающие тегасерод в отдельности или в комбинации с ингибитором протонного насоса, для лечения или профилактики повреждений желудочно-кишечного тракта |
US20090131386A1 (en) * | 2007-11-13 | 2009-05-21 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
ES2781949T3 (es) | 2007-11-13 | 2020-09-09 | Meritage Pharma Inc | Composiciones para el tratamiento de la inflamación gastrointestinal |
WO2014052625A1 (en) * | 2012-09-27 | 2014-04-03 | Levetan Claresa | Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5330982A (en) * | 1986-12-17 | 1994-07-19 | Glaxo Group Limited | Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith |
GB8630080D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
KR940006531B1 (ko) * | 1991-08-30 | 1994-07-21 | 주식회사 코오롱 | 피리딘 유도체의 제조방법 |
JPH08509736A (ja) * | 1993-04-27 | 1996-10-15 | セプラコー,インコーポレイテッド | 光学的に純粋な(−)パントプラゾールを用いる胃の疾患治療の方法と組成 |
US6156771A (en) * | 1997-08-28 | 2000-12-05 | Rubin; Walter | Method for alleviation of lower gastrointestinal disorders in a human patient |
DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
AU2002366796A1 (en) * | 2001-12-19 | 2003-07-09 | Eisai Co. Ltd | Methods using proton pump inhibitors |
-
2004
- 2004-05-04 MX MXPA05011699A patent/MXPA05011699A/es unknown
- 2004-05-04 US US10/555,055 patent/US20060235053A1/en not_active Abandoned
- 2004-05-04 WO PCT/EP2004/050694 patent/WO2004098599A2/en active Application Filing
- 2004-05-04 AU AU2004237362A patent/AU2004237362A1/en not_active Abandoned
- 2004-05-04 CA CA002524268A patent/CA2524268A1/en not_active Abandoned
- 2004-05-04 EP EP04731018A patent/EP1660084A2/en not_active Withdrawn
-
2005
- 2005-11-24 NO NO20055563A patent/NO20055563L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1660084A2 (en) | 2006-05-31 |
MXPA05011699A (es) | 2006-01-23 |
WO2004098599A2 (en) | 2004-11-18 |
US20060235053A1 (en) | 2006-10-19 |
AU2004237362A1 (en) | 2004-11-18 |
CA2524268A1 (en) | 2004-11-18 |
WO2004098599A3 (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
NO20072558L (no) | Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav | |
CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
TW200611702A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
NO20092637L (no) | Fremgangsmater for behandling | |
NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
NI200600319A (es) | Antagonistas de ccr2 de sal cuaternaria | |
GEP20084550B (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
ATE494890T1 (de) | Alpha-aminoamid-derivate zur behandlung von suchtstörungen | |
NO20055741D0 (no) | Nye kjemiske forbindelser | |
TW200505904A (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
NO20071378L (no) | Tiazolo-naftylsyrer. | |
DE602006017574D1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
NO20065859L (no) | Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser | |
DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
WO2006135694A3 (en) | Uii-modulating compounds and their use | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
NO20064793L (no) | Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade. | |
ATE410235T1 (de) | Behandlung von ballastwasser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |